CLINICAL CHARACTERISTICS AND OUTCOME OF PATIENTS RECEIVING VENETOCLAX-BASED REGIMENS IN BRAZIL: A REAL-WORLD STUDY
Introduction: The combination of venetoclax with hypomethylating agents (VEM-HM) is considered standard of care for unfit or elderly patients with acute myeloid leukemia (AML). There are several real world studies describing complications and outcome of patients treated with venetoclax-based regimen...
Αποθηκεύτηκε σε:
| Κύριοι συγγραφείς: | , , , , , , , , , , , |
|---|---|
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Elsevier
2024-10-01
|
| Σειρά: | Hematology, Transfusion and Cell Therapy |
| Διαθέσιμο Online: | http://www.sciencedirect.com/science/article/pii/S253113792400991X |
| Ετικέτες: |
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|